Leerink Partnrs Has Bearish Forecast for ARDT Q1 Earnings

Ardent Health Partners, LLC (NYSE:ARDT - Free Report) - Equities researchers at Leerink Partnrs dropped their Q1 2025 EPS estimates for Ardent Health Partners in a note issued to investors on Monday, November 11th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of $0.35 per share for the quarter, down from their prior forecast of $0.39. Leerink Partnrs has a "Strong-Buy" rating on the stock. The consensus estimate for Ardent Health Partners' current full-year earnings is $1.25 per share. Leerink Partnrs also issued estimates for Ardent Health Partners' Q2 2025 earnings at $0.58 EPS, Q3 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.56 EPS, FY2025 earnings at $1.99 EPS, FY2026 earnings at $2.27 EPS and FY2027 earnings at $2.51 EPS.

Several other research analysts have also commented on ARDT. KeyCorp assumed coverage on Ardent Health Partners in a research report on Friday, October 11th. They issued an "overweight" rating and a $24.00 target price for the company. Citigroup assumed coverage on Ardent Health Partners in a report on Monday, August 12th. They set a "buy" rating and a $21.00 target price for the company. Royal Bank of Canada reissued an "outperform" rating and issued a $23.00 price target on shares of Ardent Health Partners in a report on Thursday. Bank of America lowered Ardent Health Partners from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. initiated coverage on Ardent Health Partners in a research note on Monday, August 12th. They issued a "neutral" rating and a $18.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $21.82.

Ardent Health Partners Price Performance

Shares of ARDT traded up $0.81 during midday trading on Thursday, hitting $17.81. The company had a trading volume of 238,257 shares, compared to its average volume of 373,742. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners has a 52 week low of $14.57 and a 52 week high of $20.72. The firm has a 50 day moving average price of $18.27.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.05. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion.

Institutional Investors Weigh In On Ardent Health Partners

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Goldentree Asset Management LP purchased a new stake in shares of Ardent Health Partners during the third quarter valued at $22,897,000. MetLife Investment Management LLC acquired a new stake in Ardent Health Partners in the 3rd quarter worth approximately $135,000. BNP Paribas Financial Markets bought a new stake in Ardent Health Partners during the third quarter worth approximately $42,000. Charles Schwab Investment Management Inc. acquired a new position in Ardent Health Partners during the third quarter valued at approximately $526,000. Finally, Financial Management Professionals Inc. bought a new position in shares of Ardent Health Partners in the third quarter valued at approximately $50,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.